Pre-made Tamtuvetmab benchmark antibody ( Canine Whole mAb, anti-CD52 therapeutic antibody, Anti-HE5/CDW52/EDDM5 Antibody) for drug discovery and mechanism of action (MOA) research

Pre-Made Tamtuvetmab biosimilar, Canine Whole mAb, Anti-CD52 Antibody: Anti-HE5/CDW52/EDDM5 therapeutic antibody is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Order information

* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

Catalog No.	Package	Price(In USD)	Qty (Quantity)	Sum(In USD)
GMP-Bios-ab-548-1mg	1mg	3090
GMP-Bios-ab-548-10mg	10mg	Inquiry
GMP-Bios-ab-548-100mg	100mg	Inquiry
GMP-Bios-ab-548-xmg	＞100mg	Inquiry
			Shipping Cost:	760.00
			Total:

Description

Products Name (INN Index)	Pre-Made Tamtuvetmab biosimilar, Canine Whole mAb, Anti-CD52 Antibody: Anti-HE5/CDW52/EDDM5 therapeutic antibody
INN Name	Tamtuvetmab
Target	CD52
Format	Canine Whole mAb
Derivation	Chimeric (Dog/Rat)
Species Reactivity	Canine
CH1 Isotype	IgG2
VD LC	Kappa
Highest_Clin_Trial (Jan '20)	Unknown
Est. Status	Active
100% SI Structure	None
99% SI Structure	None
95-98% SI Structure	1bfo:HG:FE:BA:DC
Year Proposed	2015
Year Recommended	2016
Companies	Aratana Pharmaceuticals
Conditions Approved	na
Conditions Active	Canine T-cell lymphoma
Conditions Discontinued	na
Development Tech	na